Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices 68887 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–27352 Filed 11–18–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day-15–14APM] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Surveillance of Health-Related 

Workplace Absenteeism—[New]— 

National Institute for Occupational 

Safety and Health (NIOSH), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

There is currently a high global 

human health risk from emerging novel 

influenza, coronavirus and similar 

evolving pathogens, which is prompting 

the Centers for Disease Control and 

Prevention (CDC) to enhance situational 

awareness capacity for emergency 

preparedness and response. 

During the 2009 influenza A (H1N1) 

virus pandemic, NIOSH/CDC did a pilot 

study to test the feasibility of using 

national surveillance of workplace 

absenteeism to assess the pandemic’s 

impact on the workplace to plan for 

preparedness and continuity of 

operations and to contribute to health 

awareness during the emergency 

response. As part of this emergency 

effort, CDC contracted with the 

American College of Occupational and 

Environmental Medicine (ACOEM), 

which has access to a large network of 

affiliated medical directors and 

corporate health units that routinely 

compile absenteeism data, to conduct 

enhanced passive surveillance of 

absenteeism using weekly data from a 

convenience sample of sentinel 

worksites. 

Due the emergency situation at that 

time, OMB approval was erroneously 

not requested for the data collection 

activities associated with the pilot 

study. The current request seeks to 

build off of the data collected from the 

pilot and accounts for the burden 

involving all of the participants. 

From September 28, 2009, through 

March 31, 2010, 79 sentinel worksites 

representing 16 different employers 

participated in the pilot study. Each 

week, ACOEM collected reports of 

aggregated absenteeism data from the 

medical directors of the participating 

companies using an emailed, 

standardized form. ACOEM replaced 

company names with coded unique 

identifiers, and sent the aggregated data 

to CDC/NIOSH for analysis. 

The major strengths of the sentinel 

worksite approach to absenteeism 

surveillance were the use of existing, 

routinely collected data and timeliness. 

The use of existing, routinely collected 

data made the burden on participating 

companies negligible. Data were 

routinely compiled and thus could be 

collected and analyzed in near real time, 

making this approach useful, in 

principle, for providing current 

situational awareness and actionable 

intelligence that could be used to 

inform, prioritize, and evaluate 

intervention efforts during the 

pandemic. On the other hand, there 

were several limitations to the sentinel 

worksite surveillance done in 2009– 

2010, and the activity was not 

maintained after the H1N1 pandemic 

ended. 

At present, two new emerging 

infectious diseases, novel H7N9 

influenza virus and a coronavirus 

circulating in the Middle East, have 

demonstrated the need to build 

additional capacity for national 

surveillance for health-related 

workplace absenteeism so that it can be 

used to monitor the impact of these or 

any other disease that might reach 

pandemic potential and spread to the 

U.S. 

NIOSH/CDC requests permission to 

collect company absenteeism data, to be 

able to assess the impact of disease on 

a company and to identify trends in the 

spread of influenza or other novel 

disease states. This will provide an 

additional monitoring system to CDC. 

The proposed project builds on the 

2009/10 initiative and modifies the 

reporting format to collect information 

on a daily versus weekly basis. The 

companies in the program will be those 

that routinely collect absenteeism data 

thus the burden will be minimal. We 

will be asking companies to record their 

daily absenteeism numbers into an excel 

file which can be emailed to ACOEM on 

a weekly or monthly basis. The excel 

file will be pre-populated with company 

name, site and dates to ease the 

reporting burden on companies. 

ACOEM will transmit de-identified 

information on a weekly or monthly 

basis to NIOSH/CDC who will in turn 

conduct analysis on an aggregate basis. 

Data will be compiled by state and HHS 

region, as well as nationally to allow for 

trend analysis. 

The initial 16 respondents in the 

2009/10 study will be asked to 

participate and an additional 12 

companies have indicated an interest in 

participating in the data collection 

activity. The employee population 

among these 28 companies is 

approximately 293,000. 

The annualized estimated burden of 

time is 607 hours for the 28 respondents 

in the study. Respondents will complete 

the form daily; no more than 5 minutes 

per day/per respondent which translates 

to 25 minutes per week/per respondent 

or 700 minutes per week for all 

respondents. This results in an 

mstockstill on DSK4VPTVN1PROD with NOTICES

68888 Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices 

annualized burden of 607 hours per 

year. 

There are no costs to participants 

other than the time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Private companies .......................................... EXCEL data template .................................... 28 260 5/60 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–27350 Filed 11–18–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Numbers: 93.592] 

Announcing the Award of a SingleSource Program Expansion 

Supplement Grant to the National 

Resource Center on Domestic Violence 

(NRCDV) in Harrisburg, PA 

AGENCY: Family and Youth Services 

Bureau, ACYF, ACF, HHS. 

ACTION: Notice of the award of a singlesource program expansion supplement 

grant under the Family Violence 

Prevention and Services Act (FVPSA) 

Technical Assistance (TA) Project to the 

National Resource Center on Domestic 

Violence to support training and 

technical assistance activities. 

SUMMARY: The Administration for 

Children and Families (ACF), 

Administration on Children, Youth and 

Families (ACYF), Family and Youth 

Services Bureau (FYSB), Division of 

Family Violence and Prevention 

Services (DFVPS) announces the award 

of $236,000 as a single-source program 

expansion supplement to the National 

Resource Center on Domestic Violence 

in Harrisburg, PA. The grantee, funded 

under the Family Violence Protection 

and Services Act (FVPSA) program, is a 

technical assistance (TA) provider that 

assists FVPSA service providers to build 

the capacity of domestic violence 

programs. 

DATES: The period of support for the 

single-source program expansion 

supplement is September 30, 2014 

through September 29, 2015. 

FOR FURTHER INFORMATION CONTACT: 

Shawndell Dawson, Senior Program 

Specialist, Family Violence Prevention 

and Services Program, 1250 Maryland 

Avenue SW., Suite 8219, Washington, 

DC 20024. Telephone: 202–205–1476; 

Email: Shawndell.Dawson@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Supplemental award funds will support 

the grantee in providing training and 

technical assistance to domestic 

violence service providers. A portion of 

the supplemental award is contributed 

by the Centers for Disease Control (CDC) 

and Prevention’s National Center for 

Injury Prevention and Control (NCIPC), 

Division of Violence Prevention (DVP). 

This award will expand the scope of 

the NRCDV’s technical assistance 

activities to include additional activities 

concerning the prevention of intimate 

partner violence (IPV) by: (1) 

Coordinating engagement with nationallevel partners, including foundations, 

for the purpose of enhancing 

communication related to IPV 

prevention; 2) engaging in planning to 

facilitate dialogue that will include the 

sharing of tools and lessons learned 

among state domestic violence 

coalitions engaged in IPV primary 

prevention efforts; 3) continuing to 

identify and disseminate information on 

lessons learned and key findings from 

state domestic violence coalitions that 

have implemented IPV primary 

prevention activities through 

www.PreventIPVorg, and other means; 

4) maintaining a virtual workspace to 

assist in the sharing of resources among 

state and territorial domestic violence 

coalitions that are engaged in IPV 

primary prevention activities; and 5) 

facilitating regular, ongoing 

communication between the IPV 

Prevention Council, ACF/DFVPS, and 

CDC/DVP. 

In addition to the prevention 

activities, the grantee will coordinate an 

accessibility and sustainability peer-topeer technical assistance collaborative 

with three to five state domestic 

violence coalitions, which may involve 

activities such as: (1) Identifying state 

coalitions with experience in addressing 

organizational accessibility challenges 

(i.e. mental health, substance use, men, 

and adolescent boys), or sustainability 

challenges (i.e. fiscal management or 

board management); (2) coordinating 

support to domestic violence 

organizations or coalitions experiencing 

accessibility or sustainability 

challenges; and (3) developing peerinformed accessibility and sustainability 

tools and resources, and a discussion 

forum, for use by all domestic violence 

coalitions. 

Statutory Authority: Section 310 of the 

Family Violence Prevention and Services 

Act, as amended by Section 201 of the 

CAPTA Reauthorization Act of 2010, Pub. L. 

111–320. The statutory authority for the 

additional funds from the Centers for Disease 

Control and Prevention is 42 U.S.C. 

247b(k)(2) and 42 USC 280b–1 of the Public 

Health Service Act. 

Christopher Beach, 

Senior Grants Policy Specialist, Division of 

Grants Policy, Office of Administration. 

[FR Doc. 2014–27390 Filed 11–18–14; 8:45 am] 

BILLING CODE 4184–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–1855] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request: Experimental 

Studies on Consumer Perceptions of 

Modified Risk Tobacco Products 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

Experimental Studies on Consumer 

Perceptions of Modified Risk Tobacco 

Products (MRTPs). 

mstockstill on DSK4VPTVN1PROD with NOTICES